Skip to main content
Premium Trial:

Request an Annual Quote

Kevin Hrusovsky

Quanterix announced that Kevin Hrusovsky has been appointed CEO. He will continue to serve as executive chairman of the firm's board of directors. Hrusovsky brings over 20 years of experience in the life science and diagnostics industries. Prior to joining Quanterix, he was president of Life Sciences and Technologies at PerkinElmer, CEO of Caliper Life Sciences, and CEO of Zymark.

The Scan

For Better Odds

Bloomberg reports that a child has been born following polygenic risk score screening as an embryo.

Booster Decision Expected

The New York Times reports the US Food and Drug Administration is expected to authorize a booster dose of the Pfizer-BioNTech SARS-CoV-2 vaccine this week for individuals over 65 or at high risk.

Snipping HIV Out

The Philadelphia Inquirer reports Temple University researchers are to test a gene-editing approach for treating HIV.

PLOS Papers on Cancer Risk Scores, Typhoid Fever in Colombia, Streptococcus Protection

In PLOS this week: application of cancer polygenic risk scores across ancestries, genetic diversity of typhoid fever-causing Salmonella, and more.